[go: up one dir, main page]

MXPA02010600A - Inhibidor del intercambiador de sodio-hidrogeno de tipo 1. - Google Patents

Inhibidor del intercambiador de sodio-hidrogeno de tipo 1.

Info

Publication number
MXPA02010600A
MXPA02010600A MXPA02010600A MXPA02010600A MXPA02010600A MX PA02010600 A MXPA02010600 A MX PA02010600A MX PA02010600 A MXPA02010600 A MX PA02010600A MX PA02010600 A MXPA02010600 A MX PA02010600A MX PA02010600 A MXPA02010600 A MX PA02010600A
Authority
MX
Mexico
Prior art keywords
compound
tissue
prodrug
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
MXPA02010600A
Other languages
English (en)
Spanish (es)
Inventor
Eric David Cox
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MXPA02010600A publication Critical patent/MXPA02010600A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA02010600A 2000-04-28 2001-02-28 Inhibidor del intercambiador de sodio-hidrogeno de tipo 1. MXPA02010600A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
MXPA02010600A true MXPA02010600A (es) 2003-03-10

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010600A MXPA02010600A (es) 2000-04-28 2001-02-28 Inhibidor del intercambiador de sodio-hidrogeno de tipo 1.

Country Status (40)

Country Link
EP (1) EP1276737A1 (is)
JP (1) JP2003531900A (is)
KR (1) KR20020093079A (is)
CN (1) CN1225466C (is)
AP (1) AP2002002651A0 (is)
AR (1) AR028375A1 (is)
AU (1) AU2001235896A1 (is)
BG (1) BG107139A (is)
BR (1) BR0110268A (is)
CA (1) CA2407535A1 (is)
CO (1) CO5221125A1 (is)
CR (1) CR6797A (is)
CZ (1) CZ20023408A3 (is)
DZ (1) DZ3310A1 (is)
EA (1) EA004882B1 (is)
EE (1) EE200200615A (is)
GT (1) GT200100064A (is)
HN (1) HN2001000042A (is)
HR (1) HRP20020851A2 (is)
HU (1) HUP0300651A2 (is)
IL (1) IL152075A0 (is)
IS (2) IS6567A (is)
MA (1) MA26897A1 (is)
MX (1) MXPA02010600A (is)
MY (1) MY133842A (is)
NO (1) NO20025132L (is)
NZ (1) NZ521348A (is)
OA (1) OA12256A (is)
PA (1) PA8513301A1 (is)
PE (1) PE20011270A1 (is)
PL (1) PL357765A1 (is)
SK (1) SK14872002A3 (is)
SV (1) SV2002000418A (is)
TN (1) TNSN01065A1 (is)
TR (1) TR200202439T2 (is)
UA (1) UA73348C2 (is)
UY (1) UY26680A1 (is)
WO (1) WO2001083470A1 (is)
YU (1) YU79602A (is)
ZA (1) ZA200208605B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20032017A3 (cs) * 2001-01-31 2004-05-12 Pfizeráproductsáinc Ethanoláty inhibitoru sodík@vodík měniče typu �Ź způsob jejich přípravyŹ jejich použití a farmaceutický prostředekŹ který je obsahuje
WO2003051845A1 (en) * 2001-12-19 2003-06-26 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
BR0309707A (pt) * 2002-05-02 2005-02-09 Pfizer Prod Inc Tratamento de diabetes e complicações diabéticas com inibidores nhe-1
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
NZ521348A (en) 2004-09-24
UY26680A1 (es) 2001-12-28
NO20025132L (no) 2002-12-12
HN2001000042A (es) 2001-07-09
CR6797A (es) 2004-05-17
EP1276737A1 (en) 2003-01-22
MY133842A (en) 2007-11-30
CA2407535A1 (en) 2001-11-08
EA200201023A1 (ru) 2003-02-27
IS6567A (is) 2002-09-24
PL357765A1 (en) 2004-07-26
SK14872002A3 (sk) 2004-03-02
PE20011270A1 (es) 2001-12-12
DZ3310A1 (fr) 2001-11-07
UA73348C2 (en) 2005-07-15
OA12256A (en) 2003-11-06
WO2001083470A1 (en) 2001-11-08
ZA200208605B (en) 2003-10-24
IS6588A (is) 2002-10-21
EA004882B1 (ru) 2004-08-26
EE200200615A (et) 2004-04-15
BR0110268A (pt) 2003-12-30
CO5221125A1 (es) 2002-11-28
NO20025132D0 (no) 2002-10-25
AP2002002651A0 (en) 2002-12-31
TNSN01065A1 (fr) 2005-11-10
CN1426404A (zh) 2003-06-25
AU2001235896A1 (en) 2001-11-12
CN1225466C (zh) 2005-11-02
BG107139A (bg) 2003-07-31
SV2002000418A (es) 2002-07-03
CZ20023408A3 (cs) 2004-01-14
GT200100064A (es) 2002-03-22
JP2003531900A (ja) 2003-10-28
IL152075A0 (en) 2003-05-29
HRP20020851A2 (en) 2005-02-28
PA8513301A1 (es) 2003-09-05
KR20020093079A (ko) 2002-12-12
TR200202439T2 (tr) 2003-02-21
HUP0300651A2 (hu) 2003-07-28
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
AR028375A1 (es) 2003-05-07

Similar Documents

Publication Publication Date Title
US9643928B2 (en) Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
MXPA02010600A (es) Inhibidor del intercambiador de sodio-hidrogeno de tipo 1.
US6852733B2 (en) Sodium-hydrogen exchanger type 1 inhibitor
EP1224179B1 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals
US6441176B1 (en) Method for preparing sodium-hydrogen exchanger type 1 inhibitor
HK1056723A (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
AU2005201428A1 (en) Method for preparing sodium-hydrogen exchanger type 1 inhibitor

Legal Events

Date Code Title Description
FG Grant or registration